603087 甘李药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.8903.346-4.45015.20717.080
总资产报酬率 ROA (%)0.8193.047-4.09614.27015.845
投入资产回报率 ROIC (%)0.8843.318-4.40615.03913.624

边际利润分析
销售毛利率 (%)72.82973.25976.30089.03490.879
营业利润率 (%)20.18712.089-33.22347.03543.217
息税前利润/营业总收入 (%)16.6868.720-39.52542.05742.979
净利润/营业总收入 (%)17.13313.046-25.66940.22036.608

收益指标分析
经营活动净收益/利润总额(%)16.18598.43788.69193.76697.753
价值变动净收益/利润总额(%)77.28614.835-1.1875.0491.416
营业外收支净额/利润总额(%)0.391-2.9872.335-0.171-0.514

偿债能力分析
流动比率 (X)9.1087.9856.96714.15014.541
速动比率 (X)7.7426.8726.16912.80913.337
资产负债率 (%)7.4868.3019.6286.3215.986
带息债务/全部投入资本 (%)-1.307-1.134-1.156-0.949--
股东权益/带息债务 (%)-7,614.540-8,756.858-8,562.875-10,432.315-18,529.749
股东权益/负债合计 (%)1,235.8151,104.609938.6131,482.0691,570.667
利息保障倍数 (X)-4.659-2.8897.177-8.588-2,516.401

营运能力分析
应收账款周转天数 (天)52.46938.649116.69487.7510.000
存货周转天数 (天)529.819389.502576.622520.2230.000